Extavia

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2018
01220102018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Antibodies against biopharmaceuticals (anti-drug antibodies, ADA) have been a well-integrated part of the clinical care of… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2017
2017
Immunogenicity can have devastating consequences on the safety and efficacy of therapeutic proteins. Therefore, evaluating and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2016
Review
2016
INTRODUCTION Patients with multiple sclerosis (MS) generally undergo long-term treatment with disease-modifying therapies (DMTs… (More)
Is this relevant?
2014
2014
BACKGROUND Multiple sclerosis (MS) is a common complex disorder, with new treatment options emerging each year. Social media is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
OBJECTIVES Adherence to medication is essential for optimal outcomes, especially for chronic diseases such as multiple sclerosis… (More)
Is this relevant?
Review
2013
Review
2013
With the introduction of interferon- β 1b in 1993 as the first FDA-approved treatment for multiple sclerosis, the era of… (More)
Is this relevant?
Review
2012
Review
2012
The therapeutic landscape for multiple sclerosis (MS) is rapidly changing. Currently, there are eight FDA approved disease… (More)
  • table 1
  • table 2
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2011
Review
2011
The treatment era for multiple sclerosis began in 1993 with the approval of the first disease-modifying therapy. This changed the… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Relapsing-remitting multiple sclerosis (RRMS) is a chronic disease affecting about 400 000 people in the US… (More)
Is this relevant?
2010
2010
  • The Medical letter on drugs and therapeutics
  • 2010
 
Is this relevant?